+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034

  • PDF Icon

    Report

  • 408 Pages
  • December 2023
  • Region: Global
  • Visiongain
  • ID: 5806184
Description Jump to:

Overall world revenue for viral vectors and plasmid DNA manufacturing market, 2024 to 2034 in terms of value the market will surpass US$1,350 million in 2024, this work calculates. The author predicts strong revenue growth through to 2034. This work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Viral vectors and plasmids are instrumental in the field of biotechnology, especially in the context of advancements like CRISPR-Cas9 gene editing. They serve as indispensable vehicles for delivering genetic material with precision, enabling scientists to manipulate and modify genes for various purposes, from basic research to therapeutic interventions. Viral vectors, such as adeno-associated viruses (AAVs) and lentiviruses, have become central players in gene therapy, allowing for the targeted insertion of genetic material into host cells. Plasmids, on the other hand, are versatile circular pieces of DNA commonly used in molecular biology research to introduce foreign genes into cells or organisms. Their importance extends beyond gene editing to encompass a wide array of biotechnological applications, including vaccine development and protein production.

Recent developments in the biotechnology landscape further underscore the critical role of viral vectors and plasmids. In January 2023, Catalent, a prominent player in the biopharmaceutical industry, inaugurated a state-of-the-art plasmid DNA (pDNA) manufacturing facility in Gosselies, Belgium. This facility not only signifies the growing demand for plasmids but also the need for their efficient production at a commercial scale. Catalent's commitment to producing off-the-shelf plasmids to support cell and gene companies reflects the broader trend in the industry, where these genetic tools are in high demand. The integration of pDNA expertise in Gosselies with the clinical and commercial production of viral vectors for gene therapy, cell therapy, and mRNA across their network is a strategic move that ensures the continuity of the supply chain. It's a testament to the interdependence of these elements in the biotechnology ecosystem and their collective role in driving therapeutic innovations.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the viral vectors and plasmid DNA manufacturing market evolving?
  • What is driving and restraining the viral vectors and plasmid DNA manufacturing market?
  • How will each viral vectors and plasmid DNA manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each viral vectors and plasmid DNA manufacturing submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading viral vectors and plasmid DNA manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the viral vectors and plasmid DNA manufacturing projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of viral vectors and plasmid DNA manufacturing projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the viral vectors and plasmid DNA manufacturing market?
  • Where is the viral vectors and plasmid DNA manufacturing market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the viral vectors and plasmid DNA manufacturing market today, and over the next 10 years:

  • This 408-page report provides 166 tables, 183 charts /graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Viral Vectors and Plasmid DNA Manufacturing Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, this new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising viral vectors and plasmid DNA manufacturing prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Vector Type

  • Adenovirus
  • Retrovirus
  • Plasmid DNA
  • AAV
  • Lentivirus
  • Other Vectors

Application

  • Antisense and RNAi
  • Gene Therapy
  • Cell Therapy
  • Vaccinology

End-use

  • Pharma and Biopharma Companies
  • Research Institutes

Disease

  • Oncology
  • Genetic Disorders
  • Infectious Diseases
  • Others Diseases

Workflow

  • Upstream
  • Downstream

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Sweden
  • Switzerland
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Taiwan
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Viral Vectors and Plasmid DNA Manufacturing Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

  • Addgene
  • Advanced BioScience Laboratories, Inc. (ABL)
  • Aldevron
  • Altogen Biosystems
  • Amicus Therapeutics
  • ATUM
  • Batavia Biosciences B.V.
  • BioNTech IMFS
  • Biovian Oy
  • bluebird bio Inc.
  • Catalent Inc.
  • CEVEC Pharmaceuticals GmbH
  • Charles River Laboratories
  • Creative Biogene
  • FUJIFILM Diosynth Biotechnologies
  • GENEZEN
  • Lonza
  • Merck KGaA
  • Recipharm AB
  • Thermo Fisher Scientific Inc.
  • uniQure N.V.
  • VGXI Inc.
  • Virovek
  • VIVEbiotech
  • Waisman Biomanufacturing
  • WuXi AppTec
  • Yposkesi, Inc.

How will the Viral Vectors and Plasmid DNA Manufacturing Market, 2024 to 2034 report help you?

In summary, this 400+ page report provides you with the following knowledge:

  • Revenue forecasts to 2034 for Viral Vectors and Plasmid DNA Manufacturing Market, 2024 to 2034, with forecasts for vector types, application, and end-use, disease and workflow each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 24 key national markets – See forecasts for the Viral Vectors and Plasmid DNA Manufacturing Market 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Germany, UK, France, Spain, Italy, Sweden, Switzerland, China, India, Japan, Australia, South Korea, Singapore, Taiwan, Brazil, Mexico, Argentina, GCC, South Africa, and among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 27 of the major companies involved in the Viral Vectors and Plasmid DNA Manufacturing Market 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only This report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how This work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Viral Vectors and Plasmid DNA Manufacturing Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Viral Vectors and Plasmid DNA Manufacturing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Shaping the Future of Rare Disease Treatment with Viral Vector Solutions
3.2.1.2 Viral Vectors and Plasmids Play a Pivotal Role in Enabling Precision and Breakthroughs in Biotechnology
3.2.1.3 Investing in Progress Involves Capitalizing on the Viral Vector Revolution
3.2.2 Market Restraining Factors
3.2.2.1 Low Yields and Individual Optimization Hold Back Downstream Processes
3.2.2.2 Viral Vector Demand Outpaces Capacity Growth Despite Increased Investments
3.2.3 Market Opportunities
3.2.3.1 Seizing the Viral Vector Opportunity for Enhanced Healthcare Access and Cost-efficient Therapies
3.2.3.2 Advances in Genome Sequencing to Fuel Market Growth
3.2.3.3 Rising Demand for Synthetic DNA Templates in RNA Medicine
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Viral Vector Production Capacity Mapping Analysis
4.1 CMOs Capacity for Viral Vector Manufacturing
4.2 Cleanroom Suites Facilities: Leading Viral Vector Manufacturers
4.3 Surge of Investments Reshaping Contract Manufacturing Infrastructure.
4.4 Investments and Expansions in CMO/CDMO Facilities in the Cell and Gene Therapy Sector
5 Viral Vector Production & Yield Analysis
5.1 Introduction
5.2 ATMP Vectors and Manufacturing Platforms
5.3 Regulatory Challenges for Viral Vectors for Cell and Gene Therapy
6 Viral Vector Manufacturing: Process Economic Considerations and Challenges
6.1 Technological Advances in Manufacturing
6.2 Stable Producer Cell Lines
6.3 Mitigating the Challenges of Cytotoxicity through Stable Producer Lines
6.4 Key Factors in Process Development for the Utilization of Stable Producer Lines
6.5 Enhancing Efficiency and Lowering Costs: The Contribution of Stable Producer Cell Lines in CGT Production
6.5.1 Simplified Upstream Production
6.5.2 Lower Costs for Reagents and Labour
6.5.3 More Flexibility for Scale Up
6.6 When is the Time to Switch from Transient Transfection to Stable Producer Cell Lines for LVV Manufacturing?
6.7 Cost Considerations
6.8 Regulatory Expectations
7 Challenges and Advances in Recombinant Adeno-Associated Viruses (rAAVs) Gene Therapy Biomanufacturing
7.1 Introduction
8 Viral Vectors Production Process Analysis
8.1 Introduction
8.2 Upstream Unit Operations (Cell Thaw and Expansion Through Transfection)
8.3 Downstream Unit Operations (Harvest Through Purification)
8.4 Formulation/Stability and Fill/Finish
8.5 Viral Analytics
8.6 Viral Vector Production: Facilities Needs
8.7 Regulatory Standard Needs
8.8 Workforce Development and Needs
9 Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Vector Type
9.1 Key Findings
9.2 Vector Type Segment: Market Attractiveness Index
9.3 Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Vector Type
9.4 Adenovirus
9.4.1 Market Size by Region, 2024-2034 (US$ Million)
9.4.2 Market Share by Region, 2024 & 2034 (%)
9.5 Retrovirus
9.5.1 Market Size by Region, 2024-2034 (US$ Million)
9.5.2 Market Share by Region, 2024 & 2034 (%)
9.6 Plasmid DNA
9.6.1 Market Size by Region, 2024-2034 (US$ Million)
9.6.2 Market Share by Region, 2024 & 2034 (%)
9.7 AAV
9.7.1 Market Size by Region, 2024-2034 (US$ Million)
9.7.2 Market Share by Region, 2024 & 2034 (%)
9.8 Lentivirus
9.8.1 Market Size by Region, 2024-2034 (US$ Million)
9.8.2 Market Share by Region, 2024 & 2034 (%)
9.9 Other Vectors
9.9.1 Market Size by Region, 2024-2034 (US$ Million)
9.9.2 Market Share by Region, 2024 & 2034 (%)
10 Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Application
10.1 Key Findings
10.2 Application Segment: Market Attractiveness Index
10.3 Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Application
10.4 Antisense and RNAi
10.4.1 Market Size by Region, 2024-2034 (US$ Million)
10.4.2 Market Share by Region, 2024 & 2034 (%)
10.5 Gene Therapy
10.5.1 Market Size by Region, 2024-2034 (US$ Million)
10.5.2 Market Share by Region, 2024 & 2034 (%)
10.6 Cell Therapy
10.6.1 Market Size by Region, 2024-2034 (US$ Million)
10.6.2 Market Share by Region, 2024 & 2034 (%)
10.7 Vaccinology
10.7.1 Market Size by Region, 2024-2034 (US$ Million)
10.7.2 Market Share by Region, 2024 & 2034 (%)
11 Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Disease
11.1 Key Findings
11.2 Disease Segment: Market Attractiveness Index
11.3 Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Disease
11.4 Oncology
11.4.1 Market Size by Region, 2024-2034 (US$ Million)
11.4.2 Market Share by Region, 2024 & 2034 (%)
11.5 Genetic Disorders
11.5.1 Market Size by Region, 2024-2034 (US$ Million)
11.5.2 Market Share by Region, 2024 & 2034 (%)
11.6 Infectious Diseases
11.6.1 Market Size by Region, 2024-2034 (US$ Million)
11.6.2 Market Share by Region, 2024 & 2034 (%)
11.7 Other Diseases
11.7.1 Market Size by Region, 2024-2034 (US$ Million)
11.7.2 Market Share by Region, 2024 & 2034 (%)
12 Viral Vectors and Plasmid DNA Manufacturing Market Analysis by End-use
12.1 Key Findings
12.2 End-use Segment: Market Attractiveness Index
12.3 Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by End-use
12.4 Pharma and Biopharma Companies
12.4.1 Market Size by Region, 2024-2034 (US$ Million)
12.4.2 Market Share by Region, 2024 & 2034 (%)
12.5 Research Institutes
12.5.1 Market Size by Region, 2024-2034 (US$ Million)
12.5.2 Market Share by Region, 2024 & 2034 (%)
13 Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Workflow
13.1 Key Findings
13.2 Workflow Segment: Market Attractiveness Index
13.3 Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Workflow
13.4 Upstream
13.4.1 Market Size by Region, 2024-2034 (US$ Million)
13.4.2 Market Share by Region, 2024 & 2034 (%)
13.5 Downstream
13.5.1 Market Size by Region, 2024-2034 (US$ Million)
13.5.2 Market Share by Region, 2024 & 2034 (%)
14 Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Region
14.1 Key Findings
14.2 Regional Market Size Estimation and Forecast
15 North America Viral Vectors and Plasmid DNA Manufacturing Market Analysis
15.1 Key Findings
15.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Attractiveness Index
15.3 North America Viral Vectors and Plasmid DNA Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
15.4 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Country
15.5 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Vector Type
15.6 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Application
15.7 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by End-use
15.8 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Disease
15.9 North America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Workflow
15.10 U.S. Viral Vectors and Plasmid DNA Manufacturing Market Analysis
15.11 Canada Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16 Europe Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16.1 Key Findings
16.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Attractiveness Index
16.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
16.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Country
16.5 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Vector Type
16.6 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Application
16.7 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by End-use
16.8 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Disease
16.9 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Workflow
16.10 Germany Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16.11 France Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16.12 UK Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16.13 Italy Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16.14 Spain Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16.15 Sweden Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16.16 Switzerland Viral Vectors and Plasmid DNA Manufacturing Market Analysis
16.17 Rest of Europe Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17.1 Key Findings
17.2 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Attractiveness Index
17.3 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
17.4 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Country
17.5 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Vector Type
17.6 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Application
17.7 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by End-use
17.8 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Disease
17.9 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Workflow
17.10 Japan Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17.11 China Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17.12 India Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17.13 Australia Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17.14 South Korea Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17.15 Singapore Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17.16 Taiwan Viral Vectors and Plasmid DNA Manufacturing Market Analysis
17.17 Rest of Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Analysis
18 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Analysis
18.1 Key Findings
18.2 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Attractiveness Index
18.3 Latin America Viral Vectors and Plasmid DNA Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
18.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Country
18.5 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Vector Type
18.6 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Application
18.7 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by End-use
18.8 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Workflow
18.9 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Analysis
18.10 Mexico Viral Vectors and Plasmid DNA Manufacturing Market Analysis
18.11 Argentina Viral Vectors and Plasmid DNA Manufacturing Market Analysis
18.12 Rest of Latin America Viral Vectors and Plasmid DNA Manufacturing Market Analysis
19 MEA Viral Vectors and Plasmid DNA Manufacturing Market Analysis
19.1 Key Findings
19.2 MEA Viral Vectors and Plasmid DNA Manufacturing Market Attractiveness Index
19.3 MEA Viral Vectors and Plasmid DNA Manufacturing Market by Country, 2024, 2029 & 2034 (US$ Million)
19.4 MEA Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Country
19.5 MEA Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Vector Type
19.6 MEA Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Application
19.7 MEA Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by End-use
19.8 MEA Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Disease
19.9 MEA Viral Vectors and Plasmid DNA Manufacturing Market Size Estimation and Forecast by Workflow
19.10 GCC Viral Vectors and Plasmid DNA Manufacturing Market Analysis
19.11 South Africa Viral Vectors and Plasmid DNA Manufacturing Market Analysis
19.12 Rest of MEA Viral Vectors and Plasmid DNA Manufacturing Market Analysis
20 Company Profiles
20.1 Competitive Landscape, 2022
20.2 Strategic Outlook
20.1 Amicus Therapeutics
20.1.1 Company Snapshot
20.1.2 Company Overview
20.1.3 Financial Analysis
20.1.3.1 Net Revenue, 2017-2022
20.1.3.2 R&D, 2017-2022
20.1.3.3 Regional Market Shares, 2022
20.1.4 Product Benchmarking
20.1.5 Strategic Outlook
20.2 Lonza Group Ltd
20.2.1 Company Snapshot
20.2.2 Company Overview
20.2.3 Financial Analysis
20.2.3.1 Net Revenue, 2017-2022
20.2.3.2 R&D, 2017-2022
20.2.3.3 Regional Market Shares, 2022
20.2.4 Product Benchmarking
20.2.5 Strategic Outlook
20.3 Merck KGaA
20.3.1 Company Snapshot
20.3.2 Company Overview
20.3.3 Financial Analysis
20.3.3.1 Net Revenue, 2017-2022
20.3.3.2 R&D, 2017-2022
20.3.3.3 Regional Market Shares, 2022
20.3.4 Product Benchmarking
20.3.5 Strategic Outlook
20.4 uniQure N.V.
20.4.1 Company Snapshot
20.4.2 Company Overview
20.4.3 Financial Analysis
20.4.3.1 Net Revenue, 2017-2022
20.4.3.2 R&D, 2017-2022
20.4.3.3 Regional Market Shares, 2022
20.4.4 Product Benchmarking
20.4.5 Strategic Outlook
20.5 Catalent Inc
20.5.1 Company Snapshot
20.5.2 Company Overview
20.5.3 Financial Analysis
20.5.3.1 Net Revenue, 2017-2022
20.5.3.2 R&D, 2017-2022
20.5.3.3 Regional Market Shares, 2022
20.5.4 Product Benchmarking
20.5.5 Strategic Outlook
20.6 Thermo Fisher Scientific Inc.
20.6.1 Company Snapshot
20.6.2 Company Overview
20.6.3 Financial Analysis
20.6.3.1 Net Revenue, 2017-2022
20.6.3.2 R&D, 2017-2022
20.6.3.3 Regional Market Shares, 2022
20.6.4 Product Benchmarking
20.6.5 Strategic Outlook
20.7 Charles River Laboratories
20.7.1 Company Snapshot
20.7.2 Company Overview
20.7.3 Financial Analysis
20.7.3.1 Net Revenue, 2017-2022
20.7.3.2 Regional Market Shares, 2022
20.7.4 Product Benchmarking
20.7.5 Strategic Outlook
20.8 FUJIFILM Diosynth Biotechnologies
20.8.1 Company Snapshot
20.8.2 Company Overview
20.8.3 Product Benchmarking
20.8.4 Strategic Outlook
20.9 bluebird bio Inc
20.9.1 Company Snapshot
20.9.2 Company Overview
20.9.3 Financial Analysis
20.9.3.1 Net Revenue, 2017-2022
20.9.3.2 R&D, 2017-2022
20.9.4 Product Benchmarking
20.9.5 Strategic Outlook
20.10 Aldevron
20.10.1 Company Snapshot
20.10.2 Company Overview
20.10.3 Product Benchmarking
20.10.4 Strategic Outlook
20.11 Addgene
20.11.1 Company Snapshot
20.11.2 Company Overview
20.11.3 Product Benchmarking
20.12 Creative Biogene
20.12.1 Company Snapshot
20.12.2 Company Overview
20.12.3 Product Benchmarking
20.13 VIVEbiotech
20.13.1 Company Snapshot
20.13.2 Company Overview
20.13.3 Product Benchmarking
20.13.4 Strategic Outlook
20.14 Recipharm AB
20.14.1 Company Snapshot
20.14.2 Company Overview
20.14.3 Product Benchmarking
20.14.4 Strategic Outlook
20.15 Waisman Biomanufacturing
20.15.1 Company Snapshot
20.15.2 Company Overview
20.15.3 Product Benchmarking
20.15.4 Strategic Outlook
20.16 VGXI, Inc.
20.16.1 Company Snapshot
20.16.2 Company Overview
20.16.3 Product Benchmarking
20.16.4 Strategic Outlook
20.17 Batavia Biosciences B.V.
20.17.1 Company Snapshot
20.17.2 Company Overview
20.17.3 Product Benchmarking
20.17.4 Strategic Outlook
20.18 WuXi AppTec
20.18.1 Company Snapshot
20.18.2 Company Overview
20.18.3 Product Benchmarking
20.18.4 Strategic Outlook
20.19 ATUM
20.19.1 Company Snapshot
20.19.2 Company Overview
20.19.3 Product Benchmarking
20.19.4 Strategic Outlook
20.20 Altogen Biosystems
20.20.1 Company Snapshot
20.20.2 Company Overview
20.20.3 Product Benchmarking
20.21 GENEZEN
20.21.1 Company Snapshot
20.21.2 Company Overview
20.21.3 Product Benchmarking
20.21.4 Strategic Outlook
20.22 Yposkesi, Inc.
20.22.1 Company Snapshot
20.22.2 Company Overview
20.22.3 Product Benchmarking
20.22.4 Strategic Outlook
20.23 CEVEC Pharmaceuticals GmbH
20.23.1 Company Snapshot
20.23.2 Company Overview
20.23.3 Product Benchmarking
20.23.4 Strategic Outlook
20.24 Virovek
20.24.1 Company Snapshot
20.24.2 Company Overview
20.24.3 Product Benchmarking
20.24.4 Strategic Outlook
20.25 Advanced BioScience Laboratories, Inc (ABL)
20.25.1 Company Snapshot
20.25.2 Company Overview
20.25.3 Product Benchmarking
20.25.4 Strategic Outlook
20.26 Biovian Oy
20.26.1 Company Snapshot
20.26.2 Company Overview
20.26.3 Product Benchmarking
20.26.4 Strategic Outlook
20.27 BioNTech IMFS
20.27.1 Company Snapshot
20.27.2 Company Overview
20.27.3 Product Benchmarking
20.27.4 Strategic Outlook
21 Conclusion and Recommendations
21.1 Concluding Remarks
21.2 Recommendations for Market Players
List of Tables
Table 1 Cryogenic Valve Market Snapshot, 2024 & 2034 (US$ Million, CAGR %)
Table 2 Global Cryogenic Valve Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%)) (V-Shaped Recovery Scenario)
Table 3 Global Cryogenic Valve Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%)) (U-Shaped Recovery Scenario)
Table 4 Global Cryogenic Valve Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%)) (W-Shaped Recovery Scenario)
Table 5 Global Cryogenic Valve Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%)) (L-Shaped Recovery Scenario)
Table 6 Global Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 7 Low-Temperature Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 8 Ultra-Low-Temperature Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 9 Global Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 10 On/Off Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 11 Control Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 12 Relief Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 13 Global Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 14 Stainless Steel Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 15 Carbon Steel Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 16 Alloy Steel Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 17 Cryogenic Steel Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 18 Global Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 19 Energy and Power Plants Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 20 Chemical Processing Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 21 Oil and Gas Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 22 Liquefied Natural Gas Facilities Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 23 Manufacturing and Fabrication Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 24 Global Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 25 Ball Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 26 Gate Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 27 Globe Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 28 Butterfly Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 29 Check Valves Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 30 Other Types Market by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 31 Cryogenic Valve Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 32 North America Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 33 North America Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 34 North America Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 35 North America Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 36 North America Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 37 North America Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 38 North America Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 39 US Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 40 Canada Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 41 Europe Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 42 Europe Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 43 Europe Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 44 Europe Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 45 Europe Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 46 Europe Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 47 Europe Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 48 Germany Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 49 UK Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 50 France Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 51 Italy Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 52 Russia Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 53 Rest of Europe Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 54 Asia-Pacific Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 55 Asia-Pacific Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 56 Asia-Pacific Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 57 Asia-Pacific Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 58 Asia-Pacific Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 59 Asia-Pacific Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 60 Asia-Pacific Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 61 China Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 62 India Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 63 Japan Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 64 South Korea Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 65 Australia Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 66 Rest of Asia-Pacific Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 67 Middle East & Africa Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 68 Middle East & Africa Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 69 Middle East & Africa Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 70 Middle East & Africa Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 71 Middle East & Africa Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 72 Middle East & Africa Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 73 Middle East & Africa Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 74 GCC Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 75 South Africa Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 76 Rest of Middle East & Africa Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 77 Latin America Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 78 Latin America Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 79 Latin America Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 80 Latin America Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 81 Latin America Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 82 Latin America Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 83 Latin America Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 84 Brazil Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 85 Mexico Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 86 Rest of Latin America Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 87 Strategic Outlook - Contract
Table 88 Emerson Electric Co: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Emerson Electric Co: Product Benchmarking
Table 90 Emerson Electric Co: Strategic Outlook
Table 91 Schlumberger Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Schlumberger Limited: Product Benchmarking
Table 93 Schlumberger Limited: Strategic Outlook
Table 94 Parker Hannifin Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Parker Hannifin Corporation: Product Benchmarking
Table 96 Parker Hannifin Corporation: Strategic Outlook
Table 97 Flowserve Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Flowserve Corporation: Product Benchmarking
Table 99 Flowserve Corporation: Strategic Outlook
Table 100 The Weir Group PLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 The Weir Group PLC: Product Benchmarking
Table 102 The Weir Group PLC: Strategic Outlook
Table 103 HEROSE GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 HEROSE GmbH: Product Benchmarking
Table 105 Bray International, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Bray International, Inc.: Product Benchmarking
Table 107 Bray International, Inc.: Strategic Outlook
Table 108 CIRCOR International, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 CIRCOR International, Inc.: Product Benchmarking
Table 110 CIRCOR International, Inc.: Strategic Outlook
Table 111 Meca-Inox: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Meca-Inox: Product Benchmarking
Table 113 Fujikin Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 Fujikin Incorporated: Product Benchmarking
List of Figures
Figure 1 Cryogenic Valve Market Segmentation
Figure 2 Cryogenic Valve Market by Temperature Range: Market Attractiveness Index
Figure 3 Cryogenic Valve Market by Function: Market Attractiveness Index
Figure 4 Cryogenic Valve Market by Material: Market Attractiveness Index
Figure 5 Cryogenic Valve Market by Application: Market Attractiveness Index
Figure 6 Cryogenic Valve Market by Type: Market Attractiveness Index
Figure 7 Cryogenic Valve Market Attractiveness Index by Region
Figure 8 Cryogenic Valve Market: Market Dynamics
Figure 9 Natural gas production, 2022
Figure 10 Cryogenic Valve Market: Porter’s Five Forces Analysis
Figure 11 Global Cryogenic Valve Market Share Forecast by COVID, 2024-2034 (%)
Figure 12 Global Cryogenic Valve Market by Region, 2024-2034 (US$ Mn, AGR (%)) (V-Shaped Recovery Scenario)
Figure 13 Global Cryogenic Valve Market by Region, 2024-2034 (US$ Mn, AGR (%)) (U-Shaped Recovery Scenario)
Figure 14 Global Cryogenic Valve Market by Region, 2024-2034 (US$ Mn, AGR (%)) (W-Shaped Recovery Scenario)
Figure 15 Global Cryogenic Valve Market by Region, 2024-2034 (US$ Mn, AGR (%)) (L-Shaped Recovery Scenario)
Figure 16 Cryogenic Valve Market: PEST Analysis
Figure 17 Cryogenic Valve Market by Temperature Range: Market Attractiveness Index
Figure 18 Global Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%))
Figure 19 Cryogenic Valve Market Share Forecast by Temperature Range, 2024, 2029, 2034 (%)
Figure 20 Low-Temperature Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 21 Low-Temperature Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Ultra-Low-Temperature Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 23 Ultra-Low-Temperature Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Cryogenic Valve Market by Function: Market Attractiveness Index
Figure 25 Global Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%))
Figure 26 Cryogenic Valve Market Share Forecast by Function, 2024, 2029, 2034 (%)
Figure 27 On/Off Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 28 On/Off Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Control Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 30 Control Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Relief Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 32 Relief Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 33 Cryogenic Valve Market by Material: Market Attractiveness Index
Figure 34 Global Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%))
Figure 35 Cryogenic Valve Market Share Forecast by Material, 2024, 2029, 2034 (%)
Figure 36 Stainless Steel Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 37 Stainless Steel Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Carbon Steel Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 39 Carbon Steel Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 Alloy Steel Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 41 Alloy Steel Market Share Forecast by Region, 2024 & 2034 (%)
Figure 42 Cryogenic Steel Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 43 Cryogenic Steel Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Cryogenic Valve Market by Application: Market Attractiveness Index
Figure 45 Global Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%))
Figure 46 Cryogenic Valve Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 47 Energy and Power Plants Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 48 Energy and Power Plants Market Share Forecast by Region, 2024 & 2034 (%)
Figure 49 Chemical Processing Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 50 Chemical Processing Market Share Forecast by Region, 2024 & 2034 (%)
Figure 51 Oil and Gas Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 52 Oil and Gas Market Share Forecast by Region, 2024 & 2034 (%)
Figure 53 Liquefied Natural Gas Facilities Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 54 Liquefied Natural Gas Facilities Market Share Forecast by Region, 2024 & 2034 (%)
Figure 55 Manufacturing and Fabrication Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 56 Manufacturing and Fabrication Market Share Forecast by Region, 2024 & 2034 (%)
Figure 57 Cryogenic Valve Market by Type: Market Attractiveness Index
Figure 58 Global Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%))
Figure 59 Cryogenic Valve Market Share Forecast by Type, 2024, 2029, 2034 (%)
Figure 60 Ball Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 61 Ball Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 62 Gate Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 63 Gate Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 64 Globe Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 65 Globe Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 66 Butterfly Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 67 Butterfly Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 68 Check Valves Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 69 Check Valves Market Share Forecast by Region, 2024 & 2034 (%)
Figure 70 Other Types Market by Region, 2024-2034 (US$ Mn, AGR (%))
Figure 71 Other Types Market Share Forecast by Region, 2024 & 2034 (%)
Figure 72 Cryogenic Valve Market Forecast by Region 2024 and 2034 (Revenue, CAGR%)
Figure 73 Cryogenic Valve Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 74 Cryogenic Valve Market by Region, 2024-2034 (US$ Million, AGR %)
Figure 75 North America Cryogenic Valve Market Attractiveness Index
Figure 76 North America Cryogenic Valve Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 77 North America Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 78 North America Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%))
Figure 79 North America Cryogenic Valve Market Share Forecast by Country, 2024 & 2034 (%)
Figure 80 North America Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%))
Figure 81 North America Cryogenic Valve Market Share Forecast Temperature Range, 2024 & 2034 (%)
Figure 82 North America Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%))
Figure 83 North America Cryogenic Valve Market Share Forecast by Function, 2024 & 2034 (%)
Figure 84 North America Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%))
Figure 85 North America Cryogenic Valve Market Share Forecast by Material, 2024 & 2034 (%)
Figure 86 North America Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%))
Figure 87 North America Cryogenic Valve Market Share Forecast by Application, 2024 & 2034 (%)
Figure 88 North America Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%))
Figure 89 North America Cryogenic Valve Market Share Forecast by Type, 2024 & 2034 (%)
Figure 90 US Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 91 Canada Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 92 Europe Cryogenic Valve Market Attractiveness Index
Figure 93 Europe Cryogenic Valve Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 94 Europe Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 95 Europe Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%))
Figure 96 Europe Cryogenic Valve Market Share Forecast by Country, 2024 & 2034 (%)
Figure 97 Europe Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%))
Figure 98 Europe Cryogenic Valve Market Share Forecast Temperature Range, 2024 & 2034 (%)
Figure 99 Europe Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%))
Figure 100 Europe Cryogenic Valve Market Share Forecast by Function, 2024 & 2034 (%)
Figure 101 Europe Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%))
Figure 102 Europe Cryogenic Valve Market Share Forecast by Material, 2024 & 2034 (%)
Figure 103 Europe Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%))
Figure 104 Europe Cryogenic Valve Market Share Forecast by Application, 2024 & 2034 (%)
Figure 105 Europe Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%))
Figure 106 Europe Cryogenic Valve Market Share Forecast by Type, 2024 & 2034 (%)
Figure 107 Germany Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 108 UK Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 109 France Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 110 Italy Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 111 Russia Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 112 Rest of Europe Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 113 Asia-Pacific Cryogenic Valve Market Attractiveness Index
Figure 114 Asia-Pacific Cryogenic Valve Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 115 Asia-Pacific Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 116 Asia-Pacific Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%))
Figure 117 Asia-Pacific Cryogenic Valve Market Share Forecast by Country, 2024 & 2034 (%)
Figure 118 Asia-Pacific Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%))
Figure 119 Asia-Pacific Cryogenic Valve Market Share Forecast Temperature Range, 2024 & 2034 (%)
Figure 120 Asia-Pacific Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%))
Figure 121 Asia-Pacific Cryogenic Valve Market Share Forecast by Function, 2024 & 2034 (%)
Figure 122 Asia-Pacific Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%))
Figure 123 Asia-Pacific Cryogenic Valve Market Share Forecast by Material, 2024 & 2034 (%)
Figure 124 Asia-Pacific Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%))
Figure 125 Asia-Pacific Cryogenic Valve Market Share Forecast by Application, 2024 & 2034 (%)
Figure 126 Asia-Pacific Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%))
Figure 127 Asia-Pacific Cryogenic Valve Market Share Forecast by Type, 2024 & 2034 (%)
Figure 128 China Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 129 India Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 130 Japan Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 131 South Korea Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 132 Australia Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 133 Rest of Asia-Pacific Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 134 Middle East and Africa Cryogenic Valve Market Attractiveness Index
Figure 135 Middle East and Africa Cryogenic Valve Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 136 Middle East & Africa Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 137 Middle East & Africa Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%))
Figure 138 Middle East and Africa Cryogenic Valve Market Share Forecast by Country, 2024 & 2034 (%)
Figure 139 Middle East & Africa Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%))
Figure 140 Middle East and Africa Cryogenic Valve Market Share Forecast Temperature Range, 2024 & 2034 (%)
Figure 141 Middle East & Africa Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%))
Figure 142 Middle East and Africa Cryogenic Valve Market Share Forecast by Function, 2024 & 2034 (%)
Figure 143 Middle East & Africa Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%))
Figure 144 Middle East and Africa Cryogenic Valve Market Share Forecast by Material, 2024 & 2034 (%)
Figure 145 Middle East & Africa Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%))
Figure 146 Middle East and Africa Cryogenic Valve Market Share Forecast by Application, 2024 & 2034 (%)
Figure 147 Middle East & Africa Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%))
Figure 148 Middle East and Africa Cryogenic Valve Market Share Forecast by Type, 2024 & 2034 (%)
Figure 149 GCC Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 150 South Africa Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 151 Rest of Middle East & Africa Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 152 Latin America Cryogenic Valve Market Attractiveness Index
Figure 153 Latin America Cryogenic Valve Market by Region, 2024, 2029 & 2034 (US$ Million)
Figure 154 Latin America Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 155 Latin America Cryogenic Valve Market by Country, 2024-2034 (US$ Mn, AGR (%))
Figure 156 Latin America Cryogenic Valve Market Share Forecast by Country, 2024 & 2034 (%)
Figure 157 Latin America Cryogenic Valve Market by Temperature Range, 2024-2034 (US$ Mn, AGR (%))
Figure 158 Latin America Cryogenic Valve Market Share Forecast Temperature Range, 2024 & 2034 (%)
Figure 159 Latin America Cryogenic Valve Market by Function, 2024-2034 (US$ Mn, AGR (%))
Figure 160 Latin America Cryogenic Valve Market Share Forecast by Function, 2024 & 2034 (%)
Figure 161 Latin America Cryogenic Valve Market by Material, 2024-2034 (US$ Mn, AGR (%))
Figure 162 Latin America Cryogenic Valve Market Share Forecast by Material, 2024 & 2034 (%)
Figure 163 Latin America Cryogenic Valve Market by Application, 2024-2034 (US$ Mn, AGR (%))
Figure 164 Latin America Cryogenic Valve Market Share Forecast by Application, 2024 & 2034 (%)
Figure 165 Latin America Cryogenic Valve Market by Type, 2024-2034 (US$ Mn, AGR (%))
Figure 166 Latin America Cryogenic Valve Market Share Forecast by Type, 2024 & 2034 (%)
Figure 167 Brazil Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 168 Mexico Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 169 Rest of Latin America Cryogenic Valve Market by Value, 2024-2034 (US$ Mn, AGR (%))
Figure 170 Cryogenic Valve Market: Company Share, 2022
Figure 171 Emerson Electric Co.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 172 Emerson Electric Co.: R&D, 2018-2022 (US$ Million, AGR%)
Figure 173 Emerson Electric Co.: Regional Revenue Share, 2022 (%)
Figure 174 Emerson Electric Co.: Business Segment Revenue Share, 2022 (%)
Figure 175 Schlumberger Limited.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 176 Schlumberger Limited.: R&D, 2018-2022 (US$ Million, AGR%)
Figure 177 Schlumberger Limited.: Regional Revenue Share, 2022 (%)
Figure 178 Schlumberger Limited.: Business Segment Revenue Share, 2022 (%)
Figure 179 Parker Hannifin Corporation.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 180 Flowserve Corporation.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 181 Flowserve Corporation.: Regional Revenue Share, 2022 (%)
Figure 182 Flowserve Corporation.: Business Segment Revenue Share, 2022 (%)
Figure 183 The Weir Group PLC.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 184 The Weir Group PLC.: Business Segment Revenue Share, 2022 (%)

Companies Mentioned

  • Addgene
  • Advanced BioScience Laboratories, Inc. (ABL)
  • Aldevron
  • Altogen Biosystems
  • Amicus Therapeutics
  • ATUM
  • Batavia Biosciences B.V.
  • BioNTech IMFS
  • Biovian Oy
  • bluebird bio Inc.
  • Catalent Inc.
  • CEVEC Pharmaceuticals GmbH
  • Charles River Laboratories
  • Creative Biogene
  • FUJIFILM Diosynth Biotechnologies
  • GENEZEN
  • Lonza
  • Merck KGaA
  • Recipharm AB
  • Thermo Fisher Scientific Inc.
  • uniQure N.V.
  • VGXI Inc.
  • Virovek
  • VIVEbiotech
  • Waisman Biomanufacturing
  • WuXi AppTec
  • Yposkesi, Inc.
  • Abeona Therapeutics
  • Anagram Therapeutics Inc.
  • AGC Biologics
  • Atamyo Therapeutics
  • Acucela
  • Adaptimmune Therapeutics
  • Arranta Bio
  • Bio Elpida
  • BioReliance
  • Bristol Myers Squibb
  • Bunyavax BV
  • Chimeron Bio
  • Curigin
  • Cytiva
  • CorEvitas, LLC
  • Evanoa Bioscience Inc.
  • Forge Biologics
  • Genenta
  • Genentech
  • GenIbet Biopharmaceuticals
  • Hanmi Pharmaceutical
  • Immunomic Therapeutics
  • Integrum Scientific, LLC.
  • Incannex
  • Integrated DNA Technologies, Inc. (IDT)
  • Inbiomed
  • Indiana University Vector Production Facility
  • Kite
  • Novartis
  • Phoenix Nest Inc.,
  • Promega Corporation
  • Remedium Bio
  • SK pharmteco
  • Takeda Pharmaceuticals
  • T-MAXIMUM
  • VIVEbiotech
  • Xpress Biologics
  • Alliance for Regenerative Medicine
  • Bill & Melinda Gates Foundation
  • Coalition for Epidemic Preparedness Innovations (CEPI)
  • European Medicines Agency (EMA)
  • European Society of Gene and Cell Therapy
  • Food and Drug Administration
  • Health Canada
  • INADcure Foundation
  • Kobe University
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Center for Biotechnology Information
  • Tel Aviv University (TAU)
  • University of Oxford
  • University of Veterinary Medicine Hannover
  • University of Wisconsin-Madison

Related Topics

Related Reports

Viral Vectors and Plasmid DNA Global Market Report 2024 - Product Image

Viral Vectors and Plasmid DNA Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028 - Product Image

Viral Vector and Plasmid DNA Manufacturing Market - Global Forecast to 2028

  • Report
  • 317 Pages
  • Global
From
Viral Vectors and Plasmid DNA Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts- 2023 to 2031 - Product Image

Viral Vectors and Plasmid DNA Manufacturing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts- 2023 to 2031

  • Report
  • 113 Pages
  • Global
From
Global Viral Vector & Plasmid DNA Manufacturing Market by Type (Plasmid DNA, Viral Vector), Cell Line (In-vitro, In-Vivo), Transfection, Indication, Workflow, Application, End User - Forecast 2023-2030 - Product Image

Global Viral Vector & Plasmid DNA Manufacturing Market by Type (Plasmid DNA, Viral Vector), Cell Line (In-vitro, In-Vivo), Transfection, Indication, Workflow, Application, End User - Forecast 2023-2030

  • Report
  • 193 Pages
  • Global
From
Viral Vectors and Plasmid DNA Manufacturing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Viral Vectors and Plasmid DNA Manufacturing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 99 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.